Cargando…
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis
(1) Background: Osteonecrosis of the femoral head (ONFH) is characterized by impaired vascularization with ischemia resulting in bone cell death, leading to the deterioration of the hip joint. Mesenchymal stem/stromal cells (MSCs) are an attractive potential therapeutic approach in this setting. The...
Autores principales: | Blanco, Juan F., Garcia-Garcia, Francisco J., Villarón, Eva M., da Casa, Carmen, Fidalgo, Helena, López-Parra, Miriam, Santos, José A., Sánchez-Guijo, Fermín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051457/ https://www.ncbi.nlm.nih.gov/pubmed/36983120 http://dx.doi.org/10.3390/jcm12062117 |
Ejemplares similares
-
Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial
por: Gomez-Ruiz, Victoria, et al.
Publicado: (2023) -
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up
por: Blanco, Juan F., et al.
Publicado: (2019) -
Autologous mesenchymal stromal cells embedded with Tissucol Duo(®) for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
por: Jiménez, Marcelo F., et al.
Publicado: (2023) -
Autologous grafts in the treatment of avascular osteonecrosis of the femoral head
por: Marcarelli, Marco, et al.
Publicado: (2020) -
Culture-Expanded Autologous Adipose-Derived Mesenchymal Stem Cell Treatment for Osteonecrosis of the Femoral Head
por: Yoon, Pil Whan, et al.
Publicado: (2021)